Image
SumanSpeaks Capital Markets & Geopolitical Intelligence · Estd 200 6 Turnaround Watch · EPC SEPC Ltd (₹6.54): From Stressed Asset to Strategic Platform Debt down from a peak of ₹907 crore to ₹351 crore. Two SAIL orders worth ₹1,527.89 crore landed inside eight weeks. A Dubai-headquartered promoter that bailed the company out of an RBI stressed-asset restructuring is now backing an ADNOC-linked entry into the Middle East. This is what a real turnaround looks like when you actually read the balance sheet instead of the ticker. 1 The Arc: From a ₹300 IPO to a Stressed Asset to a Rescue SEPC Ltd listed in February 2008 as Shriram EPC, priced at ₹300 a share, raising ₹150 crore under the Shriram Group — one of India's most recognised financial-services names, then led by T Shivaraman...
WINNING STOKE: THINK DIFFERENT:
Good wishes for "Makar Sankranti, Pongal, Bihu, etc":
This is for my Maharastrian (Marathi) friends:
"Makar Sankranti Cha Subechcha Majha Kadun"
My recommendation Prajay Engineers Syndicate Ltd breaks the sound barrier, crosses Rs.40. The company is gradually improving its fundamentals as mentioned earlier. This stock has been recommended a number of times in this blog, if you remember, starting from Rs.13-14. It has already given huge returns to the Patient Investors...
My morning call Ambalal Sarabhai Chemicals Ltd (BSE Code: 50009) is also going great. The stock of the company looks highly undervalued considering its future potential.
Aishwarya Telecom Ltd hits the 3 rd consecutive buyer freeze in the opening trade. This stock has already given huge return to the shareholders.
My speculative call given recently at around Rs.12 to the Paid Groups is also going great, after the scrip  hit the circuits yesterday.
My recommended SEL Manufacturing Ltd around Rs.55-56, touches Rs.96 once again. This stock has also given good returns to the long term investors.

Excerpts of my morning mail to the Paid Groups:
The markets had a slight negative opening yesterday  taking cues from the global peers. Initially the market  moved sideways but this was followed by a very sharp rally ending the session comfortably above the 5200 level, which is highly encouraging for the Bulls.
Despite a momentary breach, the Nifty seems to  have found a strong support around the 5185-5180 levels. The market seems to be heading yet again to the 5280--5500 mark. Declines should thereby be utilised to initiate longs in anticipation of higher levels of 5500 on Nifty.
On the downside, 5135-5160 zone continues to be the pivot which the traders should look out for in the absolute short term.
The longer term picture continues to be purely BULLISH as long as the Nifty trades above 4900--5180 levels. Unless 5180--5160-5135, level is breached on closing basis for a couple of days, the medium term target of Nifty at 5500 still holds.
Stocks rose in the U.S. and Europe yesterday on earnings optimism and analyst upgrades, while crude oil fell below $80 per barrel after a report pointed inventory gains.
Today, Asian stocks rose for the fourth time in five days, led by mining and finance companies, as a bigger-than-estimated increase in Australian jobs boosted confidence in the global economic recovery.

 AMBALAL SARABHAI ENTERPRISES LTD.
BSE Code: 500009,
Face Value: Rs.10
CMP: Rs.14
Target: Rs.22--25,
Time Frame: 3 months time frame.

The company's principal activity is the manufacture and marketing of pharmaceutical products and bulk drugs. Its products are injectables, liquid, ointments, powders, tablets and capsules, vaccine and serum of penicillin, tetracycline or derivatives and Vitamin C and it derivatives. It operates in two segments: Pharmaceuticals and Electronics. The plants are located at Vadodara and Ahmedabad.
The promoter holding has increased from 26.12% in September, 2008 to 30.43% in September, 2009 quarter. Or on a Y-o-Y basis the promoters' holding has increased, which is a good sign. Now if you see, its peer group, then we would get surprised to find the names Cipla Ltd and Sun Pharma Ltd.

Some of the triggers are mentioned below:
* The Bulk Drugs plant of Synbiotics Limited, a wholly owned subsidiary of the company at Luna has already  commenced production activities.
* The Company has acquired manufacturing and marketing Company i.e. Suvik Hitek Pvt. Ltd. The Ethical Division has re-launched the products of Suvik and Sarabhai Chemicals in market as planned with new team of field force who has promoted products to the selected doctors in India.
* The Oncology Division is also strengthened by adding new products and team of field force. During the year under review, Oncology Division has launched two new products viz. Fludagem & Xtinib.
* For the year 2009-10, Electronics Division of the Company has lined up high end products for marketing from reputed manufacturers and has also owned new products like Turbidity meter, Hb meter, Vis- Doublebeam Spectra, etc.
* Telerad Division would try to get the maximum possible orders for Spares/other Peripherals keeping Dollar business and system sales improving.
* During FY09, the Company has promoted a Company viz. Vovantis Laboratories Pvt. Ltd., a pharmaceutical specialists with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent drug delivery system. In a short span of time, this company is having presence in the US, Europe and Asian markets with its own offices in the respective places.
* Asence Inc., a wholly-owned subsidiary of the Company, incorporated in the US specializes in the supply of quality pharmaceutical preparations (Finished Dosage Forms and Active Pharmaceutical Ingredients) to international markets. Asence Inc., through the company, pursues a multi-layered growth strategy combining internal product development, strategic alliances and collaboration with cGMP manufacturing partners, acquisitions of products and leverage of infrastructure in India and the US.
* The Company is under massive restructuring process of its business to strengthen and improve its over all financial condition. In order to reduce cost, the Company has announced VRS Scheme and many employees have opted for the said Scheme including accounts officials and staffs.
Now if you go through the June, 2009 quarter results we will find that they were good as to compared to the same quarter previous year.
I remember a couple of years back, the stock raced from Rs.12 to around 32--33 hitting continuous upper circuits....this could be repeated this time also.
The stock has consolidated in a range for a long time before starting to move up.....Hence it should be prudent to accumulate the scrip around the CMP of Rs.14. The stock is today moving up with good volumes.


Comments

Popular posts from this blog